RNASE7
Ribonuclease 7
Also known as: RAE1, RNAS7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H1E1
- Gene
- RNASE7
- Ensembl
- ENSG00000165799
- Chromosome
- 14
- Canonical length
- 156 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
The protein encoded by this gene belongs to the pancreatic ribonuclease family, a subset of the ribonuclease A superfamily. The protein has broad-spectrum antimicrobial activity against bacteria and fungi. [provided by RefSeq, Oct 2014]
Canonical amino-acid sequenceUniProt
156 residues, UniProt reviewed canonical sequence.
>Q9H1E1|RNASE7
1 MAPARAGFCP LLLLLLLGLW VAEIPVSAKP KGMTSSQWFK IQHMQPSPQA CNSAMKNINK
61 HTKRCKDLNT FLHEPFSSVA ATCQTPKIAC KNGDKNCHQS HGAVSLTMCK LTSGKHPNCR
121 YKEKRQNKSY VVACKPPQKK DSQQFHLVPV HLDRVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNASE7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 70 nTPM
- skin: 26 nTPM
- tonsil: 23 nTPM
- cervix: 13 nTPM
- vagina: 9.4 nTPM
- gallbladder: 6.2 nTPM
Single-cell type
- esophageal apical cells: 341 nCPM
- epididymal basal cells: 44 nCPM
- ocular epithelial cells: 38 nCPM
- epididymal efferent duct ciliated cells: 22 nCPM
- breast myoepithelial cells: 10 nCPM
- syncytiotrophoblasts: 8.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 0.2 nTPM
- cerebral cortex: 0.2 nTPM
- medulla oblongata: 0.2 nTPM
- white matter: 0.2 nTPM
- amygdala: 0.1 nTPM
- cerebellum: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.84
- gnomAD pLI
- 0.12
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antibacterial humoral response
- antimicrobial humoral immune response mediated by antimicrobial peptide
- cytolysis in another organism
- defense response to fungus
- defense response to Gram-negative bacterium
- defense response to Gram-positive bacterium
- innate immune response
Molecular functions
- endonuclease activity
- hydrolase activity
- lipopolysaccharide binding
- nucleic acid binding
- peptidoglycan binding
- RNA nuclease activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNASE7 as an antibody target. Whether an autoantibody or antibody against RNASE7 could matter depends on whether native RNASE7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNASE7 is annotated as secreted, so native RNASE7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label RNASE7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...